Work Groups

Long Term Follow Up Products

• Lab Quality and Follow-Up in the New England Genetics Collaborative

   link by Eaton, Roger, PhD, Comeau, Anne, PhD, Sahai, Inderneel, MD, NCC Collaborator, (December 2009)

Long Term Follow-Up Publications

• A framework for key considerations regarding point-of-care screening of newborns

  Link by Kemper AR, Kus CA, Ostrander RA, Comeau AM, Boyle CA, Dougherty D, Mann MY, Botkin JR, Green NS, Genetics in Medicine, 2012 Nov;130:e1269-77.

• Long-term follow-up to ensure quality care of individuals diagnosed with newborn screening conditions: early experience in New England

  link  Sahai I, Eaton RB, Hale JE, Mulcahy EA, Comeau AM. Genet Med. 2010;12(12 Suppl):S220-7.

• Cystic fibrosis newborn screening: using experience to optimize the screening algorithm

  link  Hale JE, Parad RB, Dorkin HL, et al.  J Inherit Metab Dis. 2010;33(Suppl 2):S255-61.

• Population-based research within a public health system; two models for common rule compliance in the Massachusetts Newborn Screening Program

  Comeau, Anne, PhD & Levin, D.; M. Bailey & T. Murray (Eds); Ethics and newborn genetics screening: new technologies, new challenges. Baltimore, MD: John Hopkins Press. 2009

• Oropharyngeal flora in healthy infants: observations and implications for cystic fibrosis care

  link  by Carlson D., McKeen E., Mitchell M., Torres B., Parad R., Comeau A.M., O'sullivan B.P.; Pediatric Pulmonology 2009 May; 44(5):497-502

• Newborn Screening Showing Decreasing Incidence of Cystic Fibrosis

  link  by JE Hale, RB Parad & Anne Comeau, New England Journal of Medicine, 2008,358:9:973-974 (Correspondence)

• Spectrum of Medium Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency detected by newborn screening.

   link  Hsu H-W, Zytkovicz TH, Comeau, AM, Strauss AW, Marsden D, Shih VE, Grady GF and Eaton RB, Pediatrics, 2008;121:e1108-e1114